Non-Standardized Pollen Allergenic Extract [EPC]

Non-Standardized Pollen Allergenic Extract [EPC] was reported 630 times

Drugs of the Non-Standardized Pollen Allergenic Extract [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 EAR CANAL ERYTHEMA 2 0.0345
1 SEXUAL ACTIVITY DECREASED 1 0.0250
2 AIR IN DEVICE ISSUE 1 0.0233
3 BREAST FIBROMA 1 0.0208
4 METHYLENETETRAHYDROFOLATE REDUCTASE GENE MUTATION 1 0.0208
5 COMPULSIVE CHEEK BITING 1 0.0196
6 RETRO-ORBITAL NEOPLASM 1 0.0189
7 CATHETER SITE PAPULE 1 0.0185
8 ADMINISTRATION SITE DISCOLOURATION 2 0.0160
9 BACTERIAL TRACHEITIS 1 0.0123
10 INFUSION SITE PAPULE 1 0.0105
11 LOCAL REACTION 7 0.0094
12 POST POLIO SYNDROME 1 0.0089
13 SENSORY LEVEL ABNORMAL 2 0.0088
14 BODY HEIGHT ABNORMAL 1 0.0086
15 BLEPHAROPLASTY 1 0.0082
16 TONSILLOLITH 1 0.0071
17 PERIPHERAL NERVE LESION 2 0.0061
18 PIRIFORMIS SYNDROME 1 0.0059
19 DYSSOMNIA 1 0.0052
20 ADMINISTRATION SITE REACTION 2 0.0052
21 VENOUS OPERATION 1 0.0051
22 JAW CYST 1 0.0046
23 PUBIC PAIN 1 0.0046
24 HAEMANGIOMA OF SKIN 2 0.0046
25 DEVICE INTOLERANCE 1 0.0042
26 SPINAL INSTABILITY 1 0.0039
27 DEVICE WIRELESS COMMUNICATION ISSUE 1 0.0039
28 VOCAL CORD POLYP 1 0.0035
29 WOUND SEPSIS 1 0.0035
30 POSITIVE AIRWAY PRESSURE THERAPY 1 0.0034
31 TRANSIENT ACANTHOLYTIC DERMATOSIS 1 0.0034
32 SYSTEMIC MASTOCYTOSIS 1 0.0033
33 DEVICE RELATED BACTERAEMIA 1 0.0032
34 EYE INFECTION VIRAL 1 0.0031
35 FIBROUS HISTIOCYTOMA 1 0.0028
36 DYSPLASTIC NAEVUS 1 0.0028
37 NASAL TURBINATE HYPERTROPHY 1 0.0027
38 IMPAIRED REASONING 1 0.0026
39 PROSTATIC PAIN 1 0.0025
40 ACOUSTIC NEUROMA 1 0.0024
41 NAIL BED DISORDER 1 0.0023
42 ALLERGY TO ARTHROPOD STING 1 0.0022
43 URINARY TRACT DISCOMFORT 1 0.0022
44 HELPLESSNESS 1 0.0021
45 OBSTRUCTIVE SLEEP APNOEA SYNDROME 3 0.0021
46 INFUSION SITE INDURATION 3 0.0020
47 COMPLICATIONS OF TRANSPLANT SURGERY 1 0.0020
48 HERPES ZOSTER OTICUS 1 0.0020
49 KELOID SCAR 1 0.0019
50 NASAL INFLAMMATION 2 0.0019
51 PALMOPLANTAR PUSTULOSIS 1 0.0019
52 TOBACCO ABUSE 1 0.0019
53 PRESBYOPIA 1 0.0018
54 OESOPHAGEAL FOOD IMPACTION 1 0.0018
55 TENOSYNOVITIS STENOSANS 1 0.0018
56 PERFUME SENSITIVITY 1 0.0018
57 EUSTACHIAN TUBE DYSFUNCTION 1 0.0017
58 ADMINISTRATION SITE PAIN 2 0.0017
59 DEVICE MAINTENANCE ISSUE 1 0.0017
60 HYPOAESTHESIA EYE 1 0.0017
61 PARKINSONIAN GAIT 1 0.0016
62 THROAT CLEARING 6 0.0016
63 NASAL PRURITUS 2 0.0016
64 INFUSION SITE IRRITATION 2 0.0016
65 OESOPHAGEAL ACHALASIA 1 0.0016
66 BONE OPERATION 1 0.0015
67 CYST RUPTURE 1 0.0015
68 ARACHNOIDITIS 1 0.0014
69 THERAPEUTIC PROCEDURE 2 0.0014
70 DERMATITIS DIAPER 1 0.0014
71 MYOFASCIAL PAIN SYNDROME 1 0.0014
72 DYSHIDROTIC ECZEMA 1 0.0014
73 GASTROINTESTINAL SCARRING 1 0.0014
74 SEBORRHOEIC KERATOSIS 2 0.0014
75 MONOCLONAL IMMUNOGLOBULIN PRESENT 1 0.0013
76 PULMONARY FUNCTION TEST ABNORMAL 2 0.0013
77 INFECTION PARASITIC 1 0.0013
78 BLISTER INFECTED 1 0.0013
79 CROUP INFECTIOUS 1 0.0013
80 EMBOLIA CUTIS MEDICAMENTOSA 1 0.0013
81 SINUSITIS FUNGAL 1 0.0012
82 VACCINATION COMPLICATION 1 0.0012
83 INFUSION SITE HAEMORRHAGE 4 0.0012
84 MYCOTIC ALLERGY 1 0.0012
85 TONGUE MOVEMENT DISTURBANCE 1 0.0012
86 ENDOCRINE OPHTHALMOPATHY 1 0.0012
87 SPINAL CORD NEOPLASM 1 0.0011
88 AORTIC VALVE STENOSIS 2 0.0011
89 OPHTHALMIC HERPES ZOSTER 2 0.0011
90 PHARYNGEAL HYPOAESTHESIA 1 0.0011
91 CATHETER SITE SWELLING 1 0.0011
92 INJECTION SITE ULCER 1 0.0011
93 SOLAR LENTIGO 1 0.0011
94 INFUSION SITE NODULE 1 0.0010
95 ULNA FRACTURE 1 0.0010
96 ADMINISTRATION SITE EXTRAVASATION 1 0.0010
97 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 1 0.0010
98 EYELID PAIN 2 0.0010
99 RESPIRATORY TRACT IRRITATION 1 0.0010
100 PHARYNGEAL ERYTHEMA 2 0.0009
101 PRODUCT COMMINGLING 1 0.0009
102 INFUSION SITE BRUISING 2 0.0009
103 INFUSION SITE MASS 1 0.0009
104 SEASONAL ALLERGY 13 0.0009
105 SUPERFICIAL INJURY OF EYE 1 0.0009
106 LARGE INTESTINAL OBSTRUCTION 2 0.0009
107 PULMONARY GRANULOMA 1 0.0009
108 INFUSION SITE INFECTION 2 0.0009
109 PRURITUS ALLERGIC 1 0.0009
110 EAR PRURITUS 3 0.0009
111 FULL BLOOD COUNT INCREASED 1 0.0008
112 MAGNETIC RESONANCE IMAGING ABNORMAL 1 0.0008
113 COLON OPERATION 1 0.0008
114 CLOSTRIDIUM COLITIS 1 0.0008
115 BLOOD IMMUNOGLOBULIN G INCREASED 1 0.0008
116 INFUSION SITE WARMTH 1 0.0008
117 EYE OEDEMA 2 0.0008
118 INTRADUCTAL PROLIFERATIVE BREAST LESION 1 0.0008
119 CALCIUM DEFICIENCY 1 0.0008
120 SINUS ARRHYTHMIA 1 0.0008
121 ANAEMIA POSTOPERATIVE 1 0.0008
122 MULTIPLE ALLERGIES 6 0.0008
123 BODY MASS INDEX INCREASED 1 0.0007
124 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 1 0.0007
125 CLUSTER HEADACHE 1 0.0007
126 AGORAPHOBIA 1 0.0007
127 RENAL ARTERY STENOSIS 1 0.0007
128 DISCHARGE 1 0.0007
129 MAST CELL ACTIVATION SYNDROME 1 0.0007
130 GLUTEN SENSITIVITY 1 0.0007
131 DERMATITIS CONTACT 8 0.0007
132 COMPLEX REGIONAL PAIN SYNDROME 1 0.0007
133 CONJUNCTIVITIS ALLERGIC 1 0.0007
134 AXILLARY PAIN 1 0.0007
135 IMPETIGO 1 0.0007
136 GASTRITIS HAEMORRHAGIC 1 0.0007
137 SMALL CELL LUNG CANCER 1 0.0007
138 MANTLE CELL LYMPHOMA 1 0.0007
139 EAR DISORDER 3 0.0007
140 BRAIN DEATH 2 0.0006
141 NEOPLASM SKIN 1 0.0006
142 INFUSION SITE PRURITUS 2 0.0006
143 TINEA PEDIS 1 0.0006
144 CUSHINGOID 2 0.0006
145 INFUSION SITE PAIN 8 0.0006
146 STRONGYLOIDIASIS 1 0.0006
147 POSTURE ABNORMAL 2 0.0006
148 DEAFNESS NEUROSENSORY 2 0.0006
149 SUSPECTED COVID-19 2 0.0006
150 MITRAL VALVE PROLAPSE 1 0.0006
151 LYME DISEASE 2 0.0006
152 SPINAL DEFORMITY 1 0.0006
153 INFUSION SITE ERYTHEMA 5 0.0006
154 VERTIGO POSITIONAL 1 0.0006
155 INFUSION SITE DISCHARGE 1 0.0006
156 BREAST CYST 1 0.0006
157 DEVICE ALARM ISSUE 1 0.0006
158 BLOOD PHOSPHORUS DECREASED 2 0.0005
159 ESSENTIAL HYPERTENSION 1 0.0005
160 BODY TEMPERATURE ABNORMAL 1 0.0005
161 SNEEZING 12 0.0005
162 HYPERTENSIVE HEART DISEASE 1 0.0005
163 BLADDER SPASM 1 0.0005
164 IMPATIENCE 1 0.0005
165 PARANASAL SINUS DISCOMFORT 2 0.0005
166 LIP DISORDER 1 0.0005
167 CARDIOPULMONARY FAILURE 2 0.0005
168 NASAL SEPTUM DEVIATION 1 0.0005
169 LIVEDO RETICULARIS 1 0.0005
170 INFUSION SITE SWELLING 3 0.0005
171 DILATATION VENTRICULAR 1 0.0005
172 NEUROGENIC BLADDER 1 0.0005
173 VASCULAR OCCLUSION 1 0.0005
174 OPTIC NEUROPATHY 1 0.0005
175 ANAPHYLACTIC REACTION 26 0.0005
176 CHAPPED LIPS 2 0.0005
177 MELANOCYTIC NAEVUS 2 0.0005
178 CORNEAL DISORDER 1 0.0005
179 CATHETERISATION CARDIAC 2 0.0005
180 RHINITIS ALLERGIC 2 0.0004
181 TONGUE BLISTERING 1 0.0004
182 THROAT IRRITATION 20 0.0004
183 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
184 MENOPAUSAL SYMPTOMS 1 0.0004
185 SPINAL COLUMN STENOSIS 2 0.0004
186 THERMAL BURN 3 0.0004
187 MYOPIA 1 0.0004
188 THROAT TIGHTNESS 11 0.0004
189 RETINAL TEAR 1 0.0004
190 ORGANISING PNEUMONIA 2 0.0004
191 DEVICE INFUSION ISSUE 1 0.0004
192 SYSTEMIC CANDIDA 1 0.0004
193 DERMATOMYOSITIS 1 0.0004
194 INSURANCE ISSUE 6 0.0004
195 ILEOSTOMY 1 0.0004
196 INCREASED UPPER AIRWAY SECRETION 2 0.0004
197 FOOD ALLERGY 3 0.0004
198 ACTINIC KERATOSIS 1 0.0004
199 PELVIC FRACTURE 3 0.0004
200 HERNIA REPAIR 1 0.0004
201 RADICULOPATHY 1 0.0004
202 SCRATCH 4 0.0004
203 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
204 ANIMAL BITE 1 0.0004
205 SINUS CONGESTION 5 0.0004
206 ORAL FUNGAL INFECTION 1 0.0004
207 RED BLOOD CELL COUNT INCREASED 1 0.0004
208 NECK MASS 1 0.0004
209 JOINT LOCK 1 0.0004
210 PHARYNGEAL DISORDER 1 0.0003
211 HYPERTONIC BLADDER 1 0.0003
212 VOMITING PROJECTILE 1 0.0003
213 DYSPNOEA AT REST 1 0.0003
214 EYELID OEDEMA 4 0.0003
215 PULMONARY PAIN 1 0.0003
216 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
217 WRONG PATIENT RECEIVED PRODUCT 1 0.0003
218 NEGATIVE THOUGHTS 1 0.0003
219 NECK INJURY 1 0.0003
220 RHINORRHOEA 22 0.0003
221 CREPITATIONS 1 0.0003
222 INFUSION SITE REACTION 1 0.0003
223 ATYPICAL PNEUMONIA 1 0.0003
224 DYSAESTHESIA 1 0.0003
225 INTERVERTEBRAL DISC DEGENERATION 3 0.0003
226 DIASTOLIC DYSFUNCTION 1 0.0003
227 INFUSION SITE EXTRAVASATION 2 0.0003
228 BRAIN FOG 5 0.0003
229 ELECTROENCEPHALOGRAM ABNORMAL 1 0.0003
230 NON-CARDIAC CHEST PAIN 1 0.0003
231 PNEUMONIA VIRAL 1 0.0003
232 INCORRECT DISPOSAL OF PRODUCT 1 0.0003
233 INJECTION SITE REACTION 21 0.0003
234 HOSPICE CARE 3 0.0003
235 SKIN INJURY 1 0.0003
236 PLANTAR FASCIITIS 1 0.0003
237 TACHYPHRENIA 1 0.0003
238 LUNG TRANSPLANT 1 0.0003
239 FAECES SOFT 2 0.0003
240 CAROTID ARTERY OCCLUSION 1 0.0003
241 UTERINE LEIOMYOMA 2 0.0003
242 AMYLASE INCREASED 1 0.0003
243 PULMONARY MASS 4 0.0003
244 RETINOPATHY 1 0.0003
245 IMPULSIVE BEHAVIOUR 1 0.0003
246 CHRONIC SINUSITIS 1 0.0003
247 LACRIMATION INCREASED 8 0.0003
248 PARANASAL SINUS HYPERSECRETION 1 0.0003
249 GASTRIC INFECTION 1 0.0003
250 BOWEL MOVEMENT IRREGULARITY 2 0.0003
251 PANIC DISORDER 1 0.0003
252 ORAL INFECTION 1 0.0003
253 GASTROINTESTINAL INFLAMMATION 2 0.0003
254 VENOUS THROMBOSIS 1 0.0003
255 OESOPHAGEAL PAIN 1 0.0003
256 IDIOPATHIC PULMONARY FIBROSIS 1 0.0003
257 BLOOD IRON DECREASED 3 0.0003
258 BLEPHARITIS 1 0.0002
259 OBSESSIVE-COMPULSIVE DISORDER 2 0.0002
260 PRODUCT DOSE OMISSION IN ERROR 7 0.0002
261 ANAPHYLACTOID REACTION 1 0.0002
262 VIRAL INFECTION 8 0.0002
263 SENSATION OF FOREIGN BODY 2 0.0002
264 SHOULDER OPERATION 1 0.0002
265 ROTATOR CUFF SYNDROME 3 0.0002
266 POOR QUALITY SLEEP 5 0.0002
267 HORDEOLUM 1 0.0002
268 SKIN SWELLING 2 0.0002
269 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
270 PULMONARY FUNCTION TEST DECREASED 1 0.0002
271 ONYCHOMYCOSIS 1 0.0002
272 HAEMORRHAGIC ANAEMIA 1 0.0002
273 GINGIVAL SWELLING 1 0.0002
274 LIMB DISCOMFORT 7 0.0002
275 URINARY TRACT DISORDER 1 0.0002
276 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
277 PNEUMONIA BACTERIAL 2 0.0002
278 ISCHAEMIA 1 0.0002
279 IRON DEFICIENCY ANAEMIA 2 0.0002
280 FEELING JITTERY 4 0.0002
281 INCREASED APPETITE 4 0.0002
282 LIMB OPERATION 1 0.0002
283 TUMOUR MARKER INCREASED 1 0.0002
284 EYE PRURITUS 7 0.0002
285 HORMONE LEVEL ABNORMAL 1 0.0002
286 PHARYNGEAL SWELLING 2 0.0002
287 APPLICATION SITE BURN 1 0.0002
288 WHEEZING 12 0.0002
289 HYPERVOLAEMIA 1 0.0002
290 SINUS DISORDER 4 0.0002
291 DIABETIC NEUROPATHY 1 0.0002
292 VEIN DISORDER 1 0.0002
293 PRODUCT SOLUBILITY ABNORMAL 1 0.0002
294 URTICARIA 33 0.0002
295 WEIGHT LOSS POOR 1 0.0002
296 EAR DISCOMFORT 2 0.0002
297 PRODUCT COLOUR ISSUE 1 0.0002
298 MUSCULOSKELETAL CHEST PAIN 3 0.0002
299 PETECHIAE 2 0.0002
300 SCIATICA 3 0.0002
301 RETCHING 4 0.0002
302 FLUSHING 19 0.0002
303 FOOD POISONING 1 0.0002
304 SKIN CANCER 4 0.0002
305 SKIN LACERATION 2 0.0002
306 NONSPECIFIC REACTION 1 0.0002
307 FOOT DEFORMITY 2 0.0002
308 STREPTOCOCCAL INFECTION 1 0.0002
309 COLECTOMY 1 0.0002
310 SINUSITIS 18 0.0002
311 UPPER RESPIRATORY TRACT INFECTION 8 0.0002
312 SOCIAL AVOIDANT BEHAVIOUR 1 0.0002
313 HYPERVENTILATION 1 0.0002
314 PRODUCT LABEL CONFUSION 1 0.0002
315 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
316 BRADYKINESIA 1 0.0002
317 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
318 CATARACT OPERATION 1 0.0002
319 ODYNOPHAGIA 1 0.0002
320 GASTROENTERITIS VIRAL 3 0.0002
321 TYPE 1 DIABETES MELLITUS 1 0.0002
322 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
323 INJECTION SITE VESICLES 1 0.0002
324 SPINAL OPERATION 2 0.0002
325 BRONCHITIS 12 0.0002
326 CYST 2 0.0002
327 PRE-EXISTING CONDITION IMPROVED 1 0.0002
328 SECRETION DISCHARGE 2 0.0002
329 HOT FLUSH 12 0.0002
330 FOREIGN BODY SENSATION IN EYES 1 0.0002
331 WHITE BLOOD CELL COUNT ABNORMAL 1 0.0002
332 ILLNESS 16 0.0002
333 INJECTION SITE INDURATION 2 0.0002
334 IMMUNE SYSTEM DISORDER 2 0.0002
335 APPETITE DISORDER 1 0.0002
336 SKIN MASS 1 0.0001
337 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
338 JOINT RANGE OF MOTION DECREASED 2 0.0001
339 PRODUCT PHYSICAL ISSUE 3 0.0001
340 BRONCHIECTASIS 1 0.0001
341 OCULAR HYPERAEMIA 7 0.0001
342 LIMB INJURY 4 0.0001
343 ABNORMAL LOSS OF WEIGHT 1 0.0001
344 CHEST DISCOMFORT 15 0.0001
345 COUGH 41 0.0001
346 ONYCHOCLASIS 1 0.0001
347 PROSTATIC SPECIFIC ANTIGEN INCREASED 2 0.0001
348 DIVERTICULITIS 4 0.0001
349 LARGE INTESTINE PERFORATION 1 0.0001
350 MASS 2 0.0001
351 CARPAL TUNNEL SYNDROME 2 0.0001
352 PAIN IN JAW 4 0.0001
353 DIVERTICULUM 1 0.0001
354 IMPAIRED QUALITY OF LIFE 2 0.0001
355 PULMONARY ARTERIAL HYPERTENSION 2 0.0001
356 HYPOKINESIA 2 0.0001
357 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
358 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
359 MAJOR DEPRESSION 1 0.0001
360 ORAL DISORDER 1 0.0001
361 BLINDNESS TRANSIENT 1 0.0001
362 SENSITIVE SKIN 1 0.0001
363 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
364 CEREBRAL DISORDER 1 0.0001
365 TOOTH DISORDER 3 0.0001
366 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 7 0.0001
367 PAROSMIA 1 0.0001
368 TENDON PAIN 1 0.0001
369 HEPATOCELLULAR CARCINOMA 1 0.0001
370 AORTIC ANEURYSM 1 0.0001
371 MULTIPLE SCLEROSIS RELAPSE 9 0.0001
372 DEVICE PHYSICAL PROPERTY ISSUE 1 0.0001
373 LIPASE INCREASED 1 0.0001
374 RENAL FAILURE CHRONIC 1 0.0001
375 PHARYNGEAL OEDEMA 2 0.0001
376 DELUSION 2 0.0001
377 PRODUCT USE COMPLAINT 2 0.0001
378 FURUNCLE 1 0.0001
379 NEUROPATHY PERIPHERAL 12 0.0001
380 RESPIRATORY TRACT CONGESTION 2 0.0001
381 PRODUCTIVE COUGH 6 0.0001
382 FRUSTRATION TOLERANCE DECREASED 1 0.0001
383 PRESYNCOPE 3 0.0001
384 BLOOD POTASSIUM INCREASED 2 0.0001
385 BACK DISORDER 2 0.0001
386 INJECTION SITE URTICARIA 3 0.0001
387 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
388 HAIR DISORDER 1 0.0001
389 BLOOD UREA INCREASED 2 0.0001
390 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2 0.0001
391 VITAMIN D DECREASED 1 0.0001
392 PSEUDOMONAS INFECTION 1 0.0001
393 INFLAMMATION 6 0.0001
394 HYSTERECTOMY 1 0.0001
395 RESPIRATORY TRACT INFECTION 3 0.0001
396 LOCAL SWELLING 2 0.0001
397 RASH MACULAR 4 0.0001
398 URINE OUTPUT DECREASED 1 0.0001
399 GROIN PAIN 1 0.0001
400 SPINAL OSTEOARTHRITIS 1 0.0001
401 HYPOXIA 4 0.0001
402 HEAD DISCOMFORT 2 0.0001
403 DRUG ERUPTION 2 0.0001
404 EAR INFECTION 3 0.0001
405 CARDIOTOXICITY 1 0.0001
406 FACIAL PAIN 1 0.0001
407 GASTROINTESTINAL INFECTION 1 0.0001
408 MYOSITIS 1 0.0001
409 ANAL INCONTINENCE 1 0.0001
410 TOOTHACHE 2 0.0001
411 PNEUMONITIS 3 0.0001
412 RESTLESS LEGS SYNDROME 2 0.0001
413 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 2 0.0001
414 RETINAL DETACHMENT 1 0.0001
415 INCREASED TENDENCY TO BRUISE 1 0.0001
416 CONJUNCTIVITIS 2 0.0001
417 SWELLING FACE 7 0.0001
418 APPENDICITIS 1 0.0001
419 FLANK PAIN 1 0.0001
420 DYSPNOEA EXERTIONAL 4 0.0001
421 LEUKAEMIA 1 0.0001
422 CONSTIPATION 23 0.0001
423 LOWER LIMB FRACTURE 2 0.0001
424 EAR PAIN 2 0.0001
425 DYSPHONIA 6 0.0001
426 VITAMIN D DEFICIENCY 1 0.0001
427 NASAL CONGESTION 6 0.0001
428 KIDNEY INFECTION 2 0.0001
429 VITREOUS FLOATERS 1 0.0001
430 THERAPY CHANGE 1 0.0001
431 LIGAMENT SPRAIN 1 0.0001
432 BLADDER DISORDER 1 0.0001
433 INABILITY TO AFFORD MEDICATION 1 0.0001
434 BLOOD POTASSIUM DECREASED 3 0.0001
435 EMPHYSEMA 1 0.0001
436 PRURITUS 38 0.0001
437 HYPOTHERMIA 1 0.0001
438 FEEDING DISORDER 2 0.0001
439 DRY THROAT 1 0.0001
440 FLUID RETENTION 5 0.0001
441 TOOTH ABSCESS 1 0.0001
442 INITIAL INSOMNIA 1 0.0001
443 PERIPHERAL SWELLING 15 0.0001
444 RIB FRACTURE 2 0.0001
445 TEMPERATURE INTOLERANCE 1 0.0001
446 POOR VENOUS ACCESS 1 0.0001
447 VENTRICULAR EXTRASYSTOLES 1 0.0001
448 WEIGHT FLUCTUATION 1 0.0001
449 DERMATITIS ATOPIC 5 0.0001
450 HEAD INJURY 3 0.0001
451 FULL BLOOD COUNT ABNORMAL 1 0.0001
452 CYSTITIS 3 0.0001
453 HEREDITARY ANGIOEDEMA 1 0.0001
454 NIGHT SWEATS 3 0.0001
455 DECREASED ACTIVITY 1 0.0001
456 PHARYNGITIS STREPTOCOCCAL 1 0.0001
457 RASH PRURITIC 5 0.0001
458 FAECES DISCOLOURED 2 0.0001
459 BIPOLAR DISORDER 1 0.0001
460 PRODUCT DISPENSING ERROR 2 0.0001
461 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
462 STAPHYLOCOCCAL INFECTION 3 0.0001
463 TOOTH FRACTURE 1 0.0001
464 DENTAL CARIES 1 0.0001
465 BLOOD PRESSURE DECREASED 6 0.0001
466 INFECTION 13 0.0001
467 GLOSSODYNIA 2 0.0001
468 BLOOD CALCIUM DECREASED 1 0.0001
469 EYE PAIN 5 0.0001
470 CHROMATURIA 2 0.0001
471 MITRAL VALVE INCOMPETENCE 1 0.0001
472 FLATULENCE 5 0.0001
473 INTERNAL HAEMORRHAGE 1 0.0001
474 NEOPLASM 1 0.0001
475 MADAROSIS 1 0.0001
476 ELECTROLYTE IMBALANCE 1 0.0001
477 POST PROCEDURAL HAEMORRHAGE 1 0.0001
478 BURNING SENSATION 6 0.0001
479 COVID-19 PNEUMONIA 1 0.0001
480 HYPERLIPIDAEMIA 1 0.0001
481 RASH ERYTHEMATOUS 4 0.0001
482 GAIT DISTURBANCE 16 0.0001
483 THYROID CANCER 1 0.0001
484 BURSITIS 1 0.0001
485 NOCTURIA 1 0.0001
486 NEURALGIA 2 0.0001
487 URINARY TRACT INFECTION 14 0.0001
488 VERTIGO 5 0.0001
489 ACCIDENTAL OVERDOSE 3 0.0001
490 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
491 DYSPNOEA 46 0.0001
492 INJECTION SITE MASS 3 0.0001
493 TENDON RUPTURE 1 0.0001
494 HAIR COLOUR CHANGES 1 0.0001
495 PNEUMONIA ASPIRATION 2 0.0001
496 INJECTION SITE DISCOLOURATION 1 0.0001
497 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
498 MUSCLE ATROPHY 1 0.0001
499 WEIGHT DECREASED 22 0.0001
500 HYPOPHAGIA 2 0.0001
501 ERYTHEMA 16 0.0001
502 ABDOMINAL PAIN UPPER 16 0.0001
503 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
504 ABDOMINAL DISCOMFORT 13 0.0001
505 NODULE 1 0.0001
506 DEAFNESS 2 0.0001
507 BEDRIDDEN 1 0.0001
508 TOOTH INFECTION 1 0.0001
509 ABNORMAL BEHAVIOUR 3 0.0001
510 ADVERSE REACTION 1 0.0001
511 INJECTION SITE BRUISING 6 0.0001
512 EYE HAEMORRHAGE 1 0.0001
513 HAIR TEXTURE ABNORMAL 1 0.0001
514 INJECTION SITE PRURITUS 5 0.0001
515 PAIN OF SKIN 2 0.0001
516 MOOD ALTERED 2 0.0001
517 TREATMENT NONCOMPLIANCE 4 0.0001
518 CORONARY ARTERY OCCLUSION 1 0.0001
519 SKIN LESION 2 0.0001
520 PERIPHERAL COLDNESS 1 0.0001
521 INJECTION SITE ERYTHEMA 9 0.0001
522 RESPIRATORY DISTRESS 2 0.0001
523 ORAL DISCOMFORT 1 0.0001
524 HUNGER 1 0.0001
525 COORDINATION ABNORMAL 1 0.0001
526 APHONIA 1 0.0001
527 WOUND 2 0.0001
528 PRODUCT DOSE OMISSION ISSUE 21 0.0001
529 BLISTER 4 0.0001
530 OXYGEN SATURATION DECREASED 4 0.0001
531 FEELING ABNORMAL 17 0.0001
532 SLEEP DISORDER 5 0.0001
533 ASTHMA 8 0.0001
534 OSTEOARTHRITIS 3 0.0001
535 SINUS TACHYCARDIA 1 0.0001
536 INTENTIONAL DOSE OMISSION 2 0.0001
537 SYNCOPE 7 0.0001
538 PARALYSIS 1 0.0001
539 HYPOACUSIS 3 0.0001
540 HERPES ZOSTER 4 0.0001
541 BALANCE DISORDER 6 0.0001
542 ANOSMIA 1 0.0001
543 HYPERTHYROIDISM 1 0.0001
544 DYSSTASIA 2 0.0001
545 ACUTE MYOCARDIAL INFARCTION 2 0.0001
546 LABORATORY TEST ABNORMAL 2 0.0001
547 CARDIOMYOPATHY 1 0.0001
548 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
549 CATARACT 4 0.0001
550 COLON CANCER 1 0.0001
551 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 12 0.0001
552 JOINT SWELLING 8 0.0001
553 CHRONIC KIDNEY DISEASE 5 0.0001
554 DEVICE FAILURE 1 0.0001
555 DISCOMFORT 4 0.0001
556 MEMORY IMPAIRMENT 9 0.0001
557 MUSCLE SPASMS 12 0.0001
558 TENDONITIS 1 0.0001
559 SOMNOLENCE 13 0.0001
560 COGNITIVE DISORDER 3 0.0001
561 SWELLING 6 0.0001
562 FATIGUE 49 0.0001
563 OBESITY 1 0.0001
564 ABSCESS 1 0.0001
565 HYPOTHYROIDISM 2 0.0001
566 WEIGHT INCREASED 14 0.0001
567 HEADACHE 39 0.0001
568 DIZZINESS 31 0.0001
569 GASTROOESOPHAGEAL REFLUX DISEASE 5 0.0001
570 INTERSTITIAL LUNG DISEASE 3 0.0001
571 MUSCLE TIGHTNESS 1 0.0001
572 DEPRESSION 14 0.0001
573 PRODUCT DOSE OMISSION 4 0.0001
574 VENTRICULAR TACHYCARDIA 1 0.0001
575 PHOTOSENSITIVITY REACTION 1 0.0001
576 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
577 DECREASED APPETITE 14 0.0001
578 TREMOR 10 0.0001
579 DRY EYE 3 0.0001
580 FUNGAL INFECTION 2 0.0001
581 SKIN DISORDER 2 0.0001
582 URINARY RETENTION 2 0.0001
583 GAIT INABILITY 2 0.0001
584 NASOPHARYNGITIS 11 0.0001
585 CELLULITIS 3 0.0001
586 TYPE 2 DIABETES MELLITUS 2 0.0001
587 CHEST PAIN 11 0.0001
588 HYPERSENSITIVITY 11 0.0001
589 ANGER 2 0.0001
590 HEMIPARESIS 1 0.0001
591 THERAPY CESSATION 3 0.0001
592 SCAR 1 0.0001
593 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
594 GASTRIC DISORDER 2 0.0001
595 MUSCULOSKELETAL DISCOMFORT 1 0.0001
596 PARANOIA 1 0.0001
597 NEOPLASM PROGRESSION 2 0.0001
598 RASH 25 0.0001
599 DIARRHOEA 37 0.0001
600 SPEECH DISORDER 3 0.0001
601 COVID-19 10 0.0001
602 BRADYCARDIA 3 0.0001
603 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
604 GOUT 1 0.0001
605 WHITE BLOOD CELL COUNT DECREASED 6 0.0001
606 BONE DISORDER 1 0.0001
607 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
608 HAEMATOCHEZIA 3 0.0001
609 DYSURIA 2 0.0001
610 FALL 18 0.0001
611 INFLUENZA 6 0.0001
612 EYE SWELLING 2 0.0001
613 NECK PAIN 3 0.0001
614 EPISTAXIS 4 0.0001
615 BLOOD SODIUM DECREASED 1 0.0001
616 RHEUMATOID ARTHRITIS 6 0.0001
617 MUSCULAR WEAKNESS 6 0.0001
618 MUSCULOSKELETAL DISORDER 1 0.0001
619 SLEEP APNOEA SYNDROME 1 0.0001
620 INJECTION SITE SWELLING 4 0.0001
621 EYE IRRITATION 3 0.0001
622 PRODUCT SUBSTITUTION ISSUE 3 0.0001
623 ACUTE RESPIRATORY FAILURE 1 0.0001
624 PLASMA CELL MYELOMA 2 0.0001
625 CHILLS 6 0.0001
626 PAIN IN EXTREMITY 15 0.0001
627 ARTHRITIS 4 0.0001
628 PARAESTHESIA 8 0.0001
629 DYSPEPSIA 5 0.0001
630 ARTHRALGIA 21 0.0001
631 DISORIENTATION 2 0.0001
632 HAEMATOCRIT DECREASED 1 0.0001
633 BLOOD PRESSURE ABNORMAL 1 0.0001
634 UPPER LIMB FRACTURE 1 0.0001
635 PRESCRIBED UNDERDOSE 1 0.0001
636 FULL BLOOD COUNT DECREASED 1 0.0000
637 PRODUCT ADMINISTRATION ERROR 1 0.0000
638 ILL-DEFINED DISORDER 3 0.0000
639 DRY MOUTH 4 0.0000
640 TASTE DISORDER 1 0.0000
641 NAUSEA 39 0.0000
642 FEELING HOT 3 0.0000
643 HAEMOGLOBIN DECREASED 5 0.0000
644 PRODUCT PREPARATION ERROR 1 0.0000
645 LUNG NEOPLASM MALIGNANT 2 0.0000
646 INFLUENZA LIKE ILLNESS 4 0.0000
647 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
648 INTENTIONAL DRUG MISUSE 1 0.0000
649 ROAD TRAFFIC ACCIDENT 2 0.0000
650 WITHDRAWAL SYNDROME 2 0.0000
651 KNEE ARTHROPLASTY 1 0.0000
652 HALLUCINATION, VISUAL 1 0.0000
653 PAIN 29 0.0000
654 EATING DISORDER 1 0.0000
655 IMPAIRED WORK ABILITY 1 0.0000
656 IRRITABLE BOWEL SYNDROME 1 0.0000
657 LIVER FUNCTION TEST INCREASED 1 0.0000
658 HYPERHIDROSIS 6 0.0000
659 PRURITUS GENERALISED 1 0.0000
660 DEVICE LEAKAGE 2 0.0000
661 AMNESIA 3 0.0000
662 PRODUCT PRESCRIBING ISSUE 1 0.0000
663 MELAENA 1 0.0000
664 INFUSION RELATED REACTION 3 0.0000
665 ASTHENIA 17 0.0000
666 DEHYDRATION 6 0.0000
667 PULMONARY OEDEMA 2 0.0000
668 ORAL PAIN 1 0.0000
669 RASH PAPULAR 1 0.0000
670 ADVERSE DRUG REACTION 4 0.0000
671 HEART RATE IRREGULAR 1 0.0000
672 PRODUCT QUALITY ISSUE 6 0.0000
673 HEPATIC ENZYME INCREASED 3 0.0000
674 PRODUCT AVAILABILITY ISSUE 1 0.0000
675 NEPHROLITHIASIS 2 0.0000
676 TINNITUS 2 0.0000
677 SKIN DISCOLOURATION 2 0.0000
678 SHOCK 1 0.0000
679 PERICARDIAL EFFUSION 1 0.0000
680 RENAL DISORDER 2 0.0000
681 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
682 PRODUCT USE ISSUE 8 0.0000
683 DISEASE PROGRESSION 5 0.0000
684 ARRHYTHMIA 2 0.0000
685 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
686 THERAPY INTERRUPTED 3 0.0000
687 MIGRAINE 4 0.0000
688 MULTIPLE SCLEROSIS 2 0.0000
689 BLOOD PRESSURE FLUCTUATION 1 0.0000
690 LOCALISED INFECTION 1 0.0000
691 MYALGIA 7 0.0000
692 UNDERDOSE 3 0.0000
693 CEREBRAL INFARCTION 1 0.0000
694 LUNG DISORDER 2 0.0000
695 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
696 PNEUMONIA 13 0.0000
697 AGEUSIA 1 0.0000
698 UNEVALUABLE EVENT 3 0.0000
699 GASTRIC CANCER 1 0.0000
700 BLOOD PRESSURE INCREASED 6 0.0000
701 RASH GENERALISED 1 0.0000
702 PHARMACEUTICAL PRODUCT COMPLAINT 1 0.0000
703 DIPLOPIA 1 0.0000
704 PSORIASIS 5 0.0000
705 ECZEMA 2 0.0000
706 SEDATION 1 0.0000
707 DEPRESSED MOOD 2 0.0000
708 INSOMNIA 10 0.0000
709 BREAST CANCER FEMALE 1 0.0000
710 CARDIAC FAILURE CONGESTIVE 3 0.0000
711 MENSTRUATION IRREGULAR 1 0.0000
712 JAUNDICE 1 0.0000
713 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
714 MALAISE 16 0.0000
715 VOMITING 17 0.0000
716 PROCEDURAL PAIN 1 0.0000
717 ARTHROPATHY 2 0.0000
718 SEPSIS 4 0.0000
719 INJECTION SITE PAIN 11 0.0000
720 PANCYTOPENIA 2 0.0000
721 DEMENTIA 1 0.0000
722 ALOPECIA 7 0.0000
723 ANXIETY 10 0.0000
724 RED BLOOD CELL COUNT DECREASED 1 0.0000
725 ANGINA PECTORIS 1 0.0000
726 PYREXIA 12 0.0000
727 PANCREATIC CARCINOMA 1 0.0000
728 BACK PAIN 8 0.0000
729 LIVER FUNCTION TEST ABNORMAL 1 0.0000
730 NEEDLE ISSUE 1 0.0000
731 GASTROINTESTINAL DISORDER 3 0.0000
732 HYPOAESTHESIA 5 0.0000
733 APHASIA 1 0.0000
734 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
735 CORONARY ARTERY DISEASE 1 0.0000
736 THERAPEUTIC RESPONSE DECREASED 2 0.0000
737 STOMATITIS 2 0.0000
738 HOSPITALISATION 5 0.0000
739 OROPHARYNGEAL PAIN 3 0.0000
740 FEMUR FRACTURE 1 0.0000
741 CARDIAC DISORDER 3 0.0000
742 SWOLLEN TONGUE 1 0.0000
743 BONE DENSITY DECREASED 1 0.0000
744 CONTUSION 3 0.0000
745 MOVEMENT DISORDER 1 0.0000
746 HIP FRACTURE 1 0.0000
747 DRUG INTOLERANCE 3 0.0000
748 CONFUSIONAL STATE 5 0.0000
749 CHOLELITHIASIS 1 0.0000
750 OSTEONECROSIS 1 0.0000
751 EYE DISORDER 1 0.0000
752 HEART RATE INCREASED 3 0.0000
753 DEVICE DIFFICULT TO USE 2 0.0000
754 NEOPLASM MALIGNANT 2 0.0000
755 NEUTROPENIA 4 0.0000
756 HAEMATURIA 1 0.0000
757 NIGHTMARE 1 0.0000
758 DEVICE USE ERROR 1 0.0000
759 HAEMORRHAGE 3 0.0000
760 MYOCARDIAL INFARCTION 5 0.0000
761 HEART RATE DECREASED 1 0.0000
762 INJURY 2 0.0000
763 LYMPHADENOPATHY 1 0.0000
764 PLATELET COUNT DECREASED 3 0.0000
765 PRODUCT ADHESION ISSUE 1 0.0000
766 CEREBRAL HAEMORRHAGE 1 0.0000
767 MYELOSUPPRESSION 1 0.0000
768 DRUG EFFECT INCOMPLETE 1 0.0000
769 PANIC ATTACK 1 0.0000
770 RESPIRATORY FAILURE 2 0.0000
771 DYSGEUSIA 2 0.0000
772 COLITIS 1 0.0000
773 DIABETES MELLITUS 2 0.0000
774 ANAEMIA 5 0.0000
775 SEIZURE 3 0.0000
776 PSORIATIC ARTHROPATHY 1 0.0000
777 OEDEMA PERIPHERAL 3 0.0000
778 DYSKINESIA 1 0.0000
779 BLINDNESS 1 0.0000
780 NEUTROPHIL COUNT DECREASED 1 0.0000
781 DEATH 21 0.0000
782 OSTEOPOROSIS 1 0.0000
783 DRUG DOSE OMISSION 4 0.0000
784 TREATMENT FAILURE 2 0.0000
785 POLLAKIURIA 1 0.0000
786 CARDIO-RESPIRATORY ARREST 1 0.0000
787 SKIN EXFOLIATION 2 0.0000
788 CEREBROVASCULAR ACCIDENT 4 0.0000
789 LOSS OF CONSCIOUSNESS 3 0.0000
790 CONDITION AGGRAVATED 7 0.0000
791 MENTAL DISORDER 1 0.0000
792 INTENTIONAL PRODUCT MISUSE 2 0.0000
793 OFF LABEL USE 20 0.0000
794 MUSCULOSKELETAL STIFFNESS 2 0.0000
795 LIVER DISORDER 1 0.0000
796 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
797 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
798 THERAPY NON-RESPONDER 1 0.0000
799 DRUG INEFFECTIVE 29 0.0000
800 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
801 ADVERSE EVENT 2 0.0000
802 ABDOMINAL PAIN 5 0.0000
803 BLOOD CHOLESTEROL INCREASED 1 0.0000
804 DYSPHAGIA 2 0.0000
805 PULMONARY EMBOLISM 2 0.0000
806 COMA 1 0.0000
807 RENAL CANCER 1 0.0000
808 BLOOD GLUCOSE DECREASED 1 0.0000
809 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
810 HYPOGLYCAEMIA 1 0.0000
811 ATRIAL FIBRILLATION 2 0.0000
812 PRODUCT USE IN UNAPPROVED INDICATION 5 0.0000
813 HYPOTENSION 4 0.0000
814 ABDOMINAL DISTENSION 2 0.0000
815 MUSCULOSKELETAL PAIN 1 0.0000
816 PANCREATITIS 1 0.0000
817 DRUG EFFECT DECREASED 1 0.0000
818 DISTURBANCE IN ATTENTION 1 0.0000
819 OVERDOSE 4 0.0000
820 OEDEMA 1 0.0000
821 MEDICATION ERROR 1 0.0000
822 THROMBOCYTOPENIA 2 0.0000
823 HYPONATRAEMIA 1 0.0000
824 INCORRECT DOSE ADMINISTERED 4 0.0000
825 CONVULSION 1 0.0000
826 LETHARGY 1 0.0000
827 BONE PAIN 1 0.0000
828 SURGERY 1 0.0000
829 BLADDER CANCER 1 0.0000
830 NO ADVERSE EVENT 3 0.0000
831 SUICIDE ATTEMPT 1 0.0000
832 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
833 VISUAL IMPAIRMENT 2 0.0000
834 EXPOSURE DURING PREGNANCY 1 0.0000
835 BLOOD GLUCOSE INCREASED 3 0.0000
836 BLOOD CREATININE INCREASED 1 0.0000
837 FEBRILE NEUTROPENIA 1 0.0000
838 DRY SKIN 2 0.0000
839 VISION BLURRED 2 0.0000
840 SKIN BURNING SENSATION 1 0.0000
841 MOBILITY DECREASED 1 0.0000
842 HALLUCINATION 1 0.0000
843 DRUG DOSE OMISSION BY DEVICE 1 0.0000
844 CARDIAC FAILURE 1 0.0000
845 PROSTATE CANCER 1 0.0000
846 THROMBOSIS 1 0.0000
847 CARDIAC ARREST 1 0.0000
848 RENAL IMPAIRMENT 1 0.0000
849 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
850 DRUG WITHDRAWAL SYNDROME 1 0.0000
851 TACHYCARDIA 1 0.0000
852 SUICIDAL IDEATION 1 0.0000
853 BREAST CANCER 1 0.0000
854 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
855 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
856 HYPERTENSION 2 0.0000
857 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
858 PALPITATIONS 1 0.0000
859 EMOTIONAL DISTRESS 1 0.0000
860 RENAL FAILURE 1 0.0000
861 ACUTE KIDNEY INJURY 1 0.0000
862 DRUG INTERACTION 1 0.0000